Dear SPM:
Here is a summary of some of the responses I received both on and off the
list about this issue. Thanks to everyone who responded. Unedited
responses are below, and my take on the responses with a summary is at the
end. Since some people wrote to me off the list I have stripped names.
----------------------------------
I guess the plan would be to assume that the residual variance is the same
for both scanners, and simply treat scans from the different scanners as
different subjects would be treated in a conventional SPM analysis. This
would preclude comparisons of e.g. Alzheimers subjects from one scanner
with controls from another, just as a comparison of condition A scans from
one subject with condition B scans from another would not be possible.
---------------------------------
I have dealt with both situations you mention, studies with different
scanners in the same institution and from different institutions. These are
PET studies, but the basic idea is the same, the fancy new machine has
better resolution and acquisition characteristics.
For a case where we moved to a new scanner on site we were lucky enough to
have similar numbers of patients and controls scanned with both machines.
So we did a separate VBM analysis with the data collected by each machine
to prove to ourselves that the results were going in the same direction on
each machine and after this proved to be the case we pooled the data and
analyzed in a standard fashion. We compared mean and standard deviation
images for the control and patient groups as well as the resulting t-maps
from the VBM modeling of control vs patient.
We were already losing resolution by registering to a MNI template, but we
otherwise would have resampled the higher resolution data into the same
voxel dimensions as the lower resolution data.
For the study across institutions it was not so simple. In fact I am still
wrestling with that data, unfortunately the other institution has both a
lower resolution PET scanner and MR scanner. The design of the study is a
pretreatment scan with multiple follow up scans, thus keeping the data from
our scans and their scans separate should not affect our results. If we do
normalize the data to a template I will be resampling our data into the
lower resolution provided by the other group.
-------------------------------------
What I was told by some experts is that it is all about doing a perfect
registration to overcome distortion differences between different scanners.
I tried a gender analysis with equal males/females from two different
scanners (both Siemens Vision 1.5 T), results were bad and completely
explained by scanner effects.
I also did a musician/non-musician comparison using equal numbers from
both scanners and never got even close to the results that I got when I
analyzed data from each scanner separately.
I know that the group at UCLA has not tried this either. If you look
through their papers, they always use images from one scanner, although
they are sitting on many datasets from different scanners as well.
------------------------------------
The Australian UHR group did some structural MRI on scans from two different
scanners:
Phillips L.J., Velakoulis D., Pantelis C., Wood S., Yuen H.P., Yung A.R.,
Desmond P., Brewer W., McGorry P.D. 2002. Non-reductions in hippocampal
volume is associated with higher risk of psychosis. Schizophr. Res. 58 145-158.
There are no great details in this paper, but it may be of use.
[ WE DON'T GET THIS JOURNAL AT OUR LIBRARY SO I HAVE NOT READ THIS PAPER. drg]
-------------------------------------
MY COMMENTS:
My take on all the responses is that VBM should probably not be done on
scans from different scanners.
Is there ever a time when it is possible, however? The only way I can
think of is if one had equal numbers of the populations to be assessed on
two different scanners, i.e., 10 patients with disease (a) on scanner A and
10 on scanner B. Then 10 normals on scanner A and 10 on scanner B. Perhaps
a non-sphericity correction would be appropriate here since scans on one
scanner vs. the other might be considered to have some dependence.
One thing that people didn't mention is that some diseases may actually
interact with the type of scanner. As an example let's say you were doing a
study on multisystem atrophy (MSA) vs. normals on 1.5 and 3 T scanners. MSA
frequently shows signal changes in the basal ganglia partially due to
deposition of iron. These changes may be more pronounced at 3T because of
greater sensitivity to inhomogeneity effects. Thus one could get a disease
by scanner interaction.
Unfortunately, no one had any ideas on how to make this problem go away
other than reacquiring scans on the new scanner.
Best regards to all,
Darren
-------------------------------------------------------------------------
Darren R. Gitelman, M.D.
Cognitive Neurology and Alzheimer¹s Disease Center
Northwestern Univ., 320 E. Superior St., Searle 11-470, Chicago, IL 60611
Voice: (312) 908-9023 Fax: (312) 908-8789
-------------------------------------------------------------------------
|